Products That Count unveils the winners of the Q4 2025 Product Awards, celebrating standout products across Human-Centered Design, IoT, and other verticals.SAN FRANCISCO, Dec. 17, 2025 /PRNewswire-PRWeb/ -- Products That Count, the most trusted source for product leadership insights and a global network of over 600,000 product managers and executives, today announced the winners of the 2025 Q4 Product Awards. Now in its eighth year, the Product Awards recognize the tools and teams enabling product leaders t ...

Elon Musk's net worth has surged to a record $648 billion — and his wealth gain this year exceeds LVMH CEO Bernard Arnault's entire $205 billion fortune, the Bloomberg Billionaires Index shows. The Tesla and SpaceX CEO's wealth has jumped by $178 billion in just two days, boosting his year-to-date gain to an unmatched $216 billion.If that figure were his entire fortune, he would rank sixth on the rich list — ahead of not just Arnault but also former Microsoft CEO Steve Ballmer and Nvidia CEO Jensen Huang. ...

格隆汇12月17日｜加拿大皇家银行：将强生公司目标价从230美元上调至240美元。 ...

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the State Street Health Care Select Sector SPDR ETF ETF (XLV) , a passively managed exchange traded fund launched on December 16, 1998.While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional and retail investors due to their low costs, transparency, flexibility, and tax efficiency.Investor-friendly, sector ETFs provide many options to gain low ris ...

Johnson & Johnson ( JNJ ) has had a solid 2025 - up ~45% (almost accounting for the total gains made in the past 5 years). The execution and financial numbers have been great too. There is scope for growthI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model v ...

目标价与评级调整 - 美银证券将强生的目标价从204美元上调至220美元 [1] - 美银证券维持对强生的"中性"评级 [1]

A California court has awarded $40 million to two women who claimed their ovarian cancer was a result of prolonged usage of Johnson & Johnson’s talcum-based baby powder. The Los Angeles Superior Court jury distributed the payout, allotting $18 million to Monica Kent and $22 million to both Deborah Schultz and her husband. This decision was made following the conclusion that Johnson & Johnson was aware of the potential harm their products could cause for several years, yet failed to notify consumers.Erik Haa ...

Link Cell Therapies Announces $60M Series A Financing Back to Home Tweet SOUTH SAN FRANCISCO, CA, Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a $60 million Series A financing. Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc. , with ...

Key Takeaways JNJ won FDA approval to expand Akeega for BRCA2-mutated metastatic castration-sensitive prostate cancer.The phase III AMPLITUDE study showed the Akeega-prednisone combo cut progression or death risk by 54%.The label expansion moves Akeega into earlier treatment, building on its 2023 approval in resistant disease.Johnson & Johnson (JNJ) announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate dual-action tablet), for a second indication in prostate cancer ...

The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's treatment for a type of blood cancer, bringing the total number of products recei... ...